Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer. Clin Cancer Res. 2017 Oct 01; 23(19):5687-5695.

View in: PubMed

subject areas

Adult
Aged
Breast Neoplasms
Circulating Tumor DNA
Disease-Free Survival
Female
Humans
Middle Aged
Mutation
Neoplasm Metastasis
Quinolines
Receptor, ErbB-2
Treatment Outcome

authors with profiles

Melody Cobleigh